Healthcare Service Usage and Costs for Elderly Patients with Obstructive Lung Disease

References

• WHO COPD fact sheet 2017 Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed 624, 2020.
   Google Scholar
• GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–1259. doi:10.1016/S0140-6736(17)32154-2.28919117
   PubMed Web of Science ®Google Scholar
• De MarcoR, PesceG, MarconA, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One. 2013;8(5):e62985. doi:10.1371/journal.pone.006298523675448
   PubMed Web of Science ®Google Scholar
• NegewoNA, GibsonPG, McDonaldVM. COPD and its comorbidities: impact, measurement and mechanisms. Respirology. 2015;20(8):1160–1171. doi:10.1111/resp.1264226374280
   PubMed Web of Science ®Google Scholar
• NegewoNA, McDonaldVM, GibsonPG. Comorbidity in chronic obstructive pulmonary disease. Respir Investig. 2015;53(6):249–258. doi:10.1016/j.resinv.2015.02.004
   PubMed Web of Science ®Google Scholar
• CavaillèsA, Brinchault-RabinG, DixmierA, et al. Comorbidities of COPD. Eur Respir Rev. 2013;22(130):454–475. doi:10.1183/09059180.0000861224293462
   PubMedGoogle Scholar
• SmithMC, WrobelJP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:871–888. doi:10.2147/COPD.S4962125210449
   PubMed Web of Science ®Google Scholar
• BeardJ, OfcerA, CasselsA. World Report on Ageing and Health. Geneva: World Health Organization; 2015 (https://apps.who.int/iris/bitstream/handle/10665/186463/9789240694811_eng.pdf. accessed 121 2019).
   Google Scholar
• World Health Organization. 2019 Integrated Care for Older People (‎‎‎‎‎ICOPE)‎‎‎‎‎ Implementation Framework: Guidance for Systems and Services. World Health Organization Available from: https://apps.who.int/iris/handle/10665/325669.License:CC BY-NC-SA3.0IGO Accessed 624, 2020.
   Google Scholar
• VanfleterenLE, SpruitMA, GroenenM, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728–735. doi:10.1164/rccm.201209-1665OC23392440
   PubMed Web of Science ®Google Scholar
• BloomDE, CafieroET, Jané-LlopisE, et al. The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum; 2011 Available from: https://www.world-heart-federation.org/wp-content/uploads/2017/05/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf. Accessed 715, 2020.
   Google Scholar
• Dal NegroRW. COPD: the annual cost-of-illness during the last two decades in Italy, and its mortality predictivity power. Healthcare (Basel). 2019;7:35. doi:10.3390/healthcare7010035
   PubMedGoogle Scholar
• NunesC, PereiraAM, Morais-AlmeidaM. Asthma costs and social impact. Asthma Res Pract. 2017;3(1):1. doi:10.1186/s40733-016-0029-328078100
   PubMedGoogle Scholar
• ManninoDM, ThornD, SwensenA, HolguinF. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–969. doi:10.1183/09031936.0001240818579551
   PubMed Web of Science ®Google Scholar
• SinBA, AkkocaO, SaryalS, OnerF, MisirligilZ. Differences between asthma and COPD in the elderly. J Investig Allergol Clin Immunol. 2006;16(1):44–50.
   PubMed Web of Science ®Google Scholar
• The Johns Hopkins University. ACG System Version 11.0 Technical Reference Guide. 11.0th ed. The Johns Hopkins University; 2014.
   Google Scholar
• DGR N. 1103 del 01/07/14. Il sistema ACG (Adjusted Clinical Group) per la valutazione e gestione del case-mix territoriale nella Regione del Veneto. Approvazione dei risultati del secondo anno (DGR 498/2013) e avvio del terzo e quarto anno di attività. 2014 Lug 01, (9^ legislatura)
   Google Scholar
• DGR N. 439 del 20/03/12. Il sistema ACG (Adjusted Clinical Group) per la valutazione e gestione del case-mix territoriale nella Regione Veneto: progetto pilota per l’adozione di strumenti innovativi di misurazione del rischio, analisi, programmazione. 2012 3 20.
   Google Scholar
• DGR N. 498 del 16/04/13. Il sistema ACG (Adjusted Clinical Group) per la valutazione e gestione del case-mix territoriale nella Regione del Veneto. Approvazione dei risultati del primo anno (DGR 439/2012) e avvio del secondo anno e terzo anno di attività. 2013 Apr 16,(9^ legislatura).
   Google Scholar
• BarnettK, MercerSW, NorburyM, WattG, WykeS, GuthrieB. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37‐43. doi:10.1016/S0140-6736(12)60240-2
   PubMed Web of Science ®Google Scholar
• ViolanC, Foguet-BoreuQ, Flores-MateoG, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One. 2014;9(7):e102149. doi:10.1371/journal.pone.010214925048354
   PubMed Web of Science ®Google Scholar
• WatsonL, VestboJ, PostmaDS, et al. Gender differences in the management and experience of chronic obstructive pulmonary disease. Respir Med. 2004;98(12):1207–1213. doi:10.1016/j.rmed.2004.05.00415588042
   PubMed Web of Science ®Google Scholar
• BujaA, De PoloA, De BattistiE, et al. The importance of sex as a risk factor for hospital readmissions due to pulmonary diseases. BMC Public Health. 2020;20(1):53. doi:10.1186/s12889-019-8138-631937272
   PubMed Web of Science ®Google Scholar
• AyanianJZ, EpsteinAM. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med. 1991;325(4):221–225. doi:10.1056/NEJM1991072532504012057022
   PubMed Web of Science ®Google Scholar
• BeeryTA. Gender bias in the diagnosis and treatment of coronary artery disease. Heart Lung. 1995;24(6):427–435. doi:10.1016/s0147-9563(95)80020-48582818
   PubMed Web of Science ®Google Scholar
• GanSC, BeaverSK, HouckPM, MacLehoseRF, LawsonHW, ChanL. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med. 2000;343(1):8–15. doi:10.1056/NEJM20000706343010210882763
   PubMed Web of Science ®Google Scholar
• AlterDA, NaylorCD, AustinPC, TuJV. Biology or bias: practice patterns and long-term outcomes for men and women with acute myocardial infarction. J Am Coll Cardiol. 2002;39(12):1909–1916. doi:10.1016/s0735-1097(02)01892-212084587
   PubMed Web of Science ®Google Scholar
• AgustiA, CalverleyPM, CelliB, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11(1):122. doi:10.1186/1465-9921-11-12220831787
   PubMed Web of Science ®Google Scholar
• HenochI, StrangS, LöfdahlCG, Ekberg-JanssonA. Management of COPD, equal treatment across age, gender, and social situation? A register study. Int J Chron Obstruct Pulmon Dis. 2016;11:2681–2690. doi:10.2147/COPD.S11523827822030
   PubMed Web of Science ®Google Scholar
• WestneyG, ForemanMG, XuJ, Henriques KingM, FlenaughE, RustG. Impact of comorbidities among Medicaid enrollees with chronic obstructive pulmonary disease, United States, 2009. Prev Chronic Dis. 2017;14:E31. doi:10.5888/pcd14.16033328409741
   PubMed Web of Science ®Google Scholar
• LisspersK, LarssonK, JohanssonG, et al. Economic burden of COPD in a Swedish cohort: the ARCTIC study. Int J Chron Obstruct Pulmon Dis. 2018;13:275–285. doi:10.2147/COPD.S14963329391785
   PubMed Web of Science ®Google Scholar
• JanssonSA, BackmanH, RönmarkE, LundbäckB, LindbergA. Hospitalization due to co-morbid conditions is the main cost driver among subjects with COPD – a report from the population-based OLIN COPD Study. COPD. 2015;12(4):381–389. doi:10.3109/15412555.2014.97408925415366
   PubMedGoogle Scholar
• LinPJ, ShayaFT, ScharfSM. Economic implications of comorbid conditions among Medicaid beneficiaries with COPD. Respir Med. 2010;104(5):697–704. doi:10.1016/j.rmed.2009.11.00919954941
   PubMed Web of Science ®Google Scholar
• Simon-TuvalT, ScharfSM, MaimonN, Bernhard-ScharfBJ, ReuveniH, TarasiukA. Determinants of elevated healthcare utilization in patients with COPD. Respir Res. 2011;12(1):7. doi:10.1186/1465-9921-12-721232087
   PubMed Web of Science ®Google Scholar
• SchwabP, DhamaneAD, HopsonSD, et al. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis. 2017;12:735–744. doi:10.2147/COPD.S11225628260880
   PubMed Web of Science ®Google Scholar
• JantunenJ, HaahtelaT, SalimäkiJ, et al. Multimorbidity in asthma, allergic conditions and COPD increase disease severity, drug use and costs: the Finnish Pharmacy Survey. Int Arch Allergy Immunol. 2019;179(4):273–280. doi:10.1159/00049886130999310
   PubMed Web of Science ®Google Scholar
• MillerJ, EdwardsLD, AgustíA, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013;107(9):1376–1384. doi:10.1016/j.rmed.2013.05.00123791463
   PubMed Web of Science ®Google Scholar